Blog

MBI Researchers identify new immunotherapy targets for medulloblastoma

Photo taken from McKnight Brain Institute of the University of Florida/LinkedIn

Aug 21, 2024, 14:07

MBI Researchers identify new immunotherapy targets for medulloblastoma

McKnight Brain Institute of the University of Florida shared on LinkedIn:

“MBI researchers led a study published today in Genome Medicine analyzing genetic data from 170 medulloblastoma patients across four subtypes to identify potential new targets for immunotherapy treatment of the disease.

‘This work provides a foundation for developing more personalized immunotherapies that could be safer and more effective than current treatments,’ said first author Dr. Changlin Yang.”

‘Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma‘

Authors: Changlin Yang, Vrunda Trivedi, Kyle Dyson, Tongjun Gu, Kate M. Candelario, Oleg Yegorov and Duane A. Mitchell

MBI Researchers identify new immunotherapy targets for medulloblastoma

Source: McKnight Brain Institute of the University of Florida/LinkedIn

cancer Changlin Yang Duane A. Mitchell Genome Medicine immunotherapy Kate M. Candelario Kyle Dyson McKnight Brain Institute of the University of Florida medulloblastoma Oleg Yegorov OncoDaily Oncology Tongjun Gu Vrunda Trivedi

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage